格隆汇3月6日丨根据联交所最新权益披露资料显示,2026年3月4日,德琪医药-B(06996.HK)获China International Capital Corporation Limited在场内以每股均价3.0616港元增持好仓62.7万股,涉资约192万港元。增持后,China International Capital Corporation Limited最新持好仓数目为...
Source Link格隆汇3月6日丨根据联交所最新权益披露资料显示,2026年3月4日,德琪医药-B(06996.HK)获China International Capital Corporation Limited在场内以每股均价3.0616港元增持好仓62.7万股,涉资约192万港元。增持后,China International Capital Corporation Limited最新持好仓数目为...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.